- Home
- KRMD vs XBIT Comparison
KRMD vs XBIT Comparison
Compare KRMD & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- XBIT
- Stock Information
- Founded
- KRMD 1980
- XBIT 2005
- Country
- KRMD United States
- XBIT United States
- Employees
- KRMD N/A
- XBIT N/A
- Industry
- KRMD Medical/Dental Instruments
- XBIT Pharmaceuticals and Biotechnology
- Sector
- KRMD Health Care
- XBIT Health Care
- Exchange
- KRMD Nasdaq
- XBIT Nasdaq
- Market Cap
- KRMD 187.5M
- XBIT 194.5M
- IPO Year
- KRMD N/A
- XBIT 2015
- Fundamental
- Price
- KRMD $4.60
- XBIT $3.25
- Analyst Decision
- KRMD Strong Buy
- XBIT
- Analyst Count
- KRMD 5
- XBIT 0
- Target Price
- KRMD $4.50
- XBIT N/A
- AVG Volume (30 Days)
- KRMD 157.7K
- XBIT 52.0K
- Earning Date
- KRMD 03-12-2025
- XBIT 03-14-2025
- Dividend Yield
- KRMD N/A
- XBIT N/A
- EPS Growth
- KRMD N/A
- XBIT N/A
- EPS
- KRMD N/A
- XBIT N/A
- Revenue
- KRMD $31,993,796.00
- XBIT N/A
- Revenue This Year
- KRMD $20.04
- XBIT N/A
- Revenue Next Year
- KRMD $14.15
- XBIT N/A
- P/E Ratio
- KRMD N/A
- XBIT N/A
- Revenue Growth
- KRMD 11.57
- XBIT N/A
- 52 Week Low
- KRMD $2.01
- XBIT $3.25
- 52 Week High
- KRMD $5.05
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- KRMD 66.80
- XBIT 26.88
- Support Level
- KRMD $4.16
- XBIT $3.40
- Resistance Level
- KRMD $4.40
- XBIT $3.69
- Average True Range (ATR)
- KRMD 0.23
- XBIT 0.20
- MACD
- KRMD 0.03
- XBIT 0.05
- Stochastic Oscillator
- KRMD 63.71
- XBIT 3.85
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.